A 32-year-old man from rural Maharashtra presents with a 3-week history of persistent cough, fever, and night sweats. Clinical examination reveals crackles in the right upper lobe. Chest X-ray shows an infiltrate with a cavity in the right apical region. What is the investigation of choice to confirm pulmonary tuberculosis and determine drug susceptibility?

Explanation

## Investigation of Choice for Pulmonary TB Confirmation and Drug Susceptibility ### Why GeneXpert MTB/RIF (Xpert MTB/RIF) is the Answer **Key Point:** GeneXpert MTB/RIF is the WHO-endorsed and NTEP-recommended first-line investigation for TB diagnosis and simultaneous detection of rifampicin resistance in a single test. **High-Yield:** As per NTEP 2023 guidelines and WHO recommendations, Xpert MTB/RIF is the investigation of choice for: 1. Diagnosis of TB (sensitivity ~95% in sputum-positive cases) 2. Detection of rifampicin resistance (proxy for MDR-TB) 3. Rapid turnaround time (2 hours) 4. Minimal sample preparation required ### Comparison of Diagnostic Modalities | Investigation | Sensitivity | Specificity | Time to Result | Drug Susceptibility | WHO Status | |---|---|---|---|---|---| | **Xpert MTB/RIF** | 95% (sputum+) | 99% | 2 hours | Rifampicin only | **Recommended 1st-line** | | Sputum smear microscopy | 60–80% | 95% | 1–2 days | None | Confirmatory only | | Culture (LJ medium) | 95% | 100% | 2–8 weeks | Full DST available | Gold standard (slow) | | TST | N/A | N/A | 48–72 hrs | None | Screening only | | HRCT chest | N/A | N/A | Minutes | None | Supportive imaging | **Clinical Pearl:** In this case, the patient has a cavitary lesion (high bacterial load), making him an ideal candidate for rapid molecular testing. Xpert MTB/RIF will provide both diagnosis and rifampicin resistance status within 2 hours, enabling immediate treatment initiation. **Mnemonic:** **XPERT** = eXpedited, eXtremely sensitive, eXtremely specific, eXternal validation by WHO, eXcellent for drug resistance. ### NTEP Algorithm ```mermaid flowchart TD A[Presumptive TB case]:::outcome --> B{Sputum smear positive?}:::decision B -->|Yes| C[Xpert MTB/RIF on sputum]:::action B -->|No| D[Xpert MTB/RIF on sputum]:::action C --> E{MTB detected?}:::decision D --> E E -->|Yes| F{Rifampicin resistant?}:::decision E -->|No| G[Rule out TB / Investigate further]:::outcome F -->|Yes| H[Initiate MDR-TB treatment]:::action F -->|No| I[Initiate standard TB treatment]:::action ``` **Key Point:** Xpert MTB/RIF is now the recommended initial test for all presumptive TB cases (pulmonary and extrapulmonary) in India under NTEP, replacing sputum smear microscopy as the first-line investigation.